|
ATCC
human ovarian cancer cell line skov3 Human Ovarian Cancer Cell Line Skov3, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/SK-OV-3/pm42983439-28-1-28 Average 99 stars, based on 1 article reviews
human ovarian cancer cell line skov3 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
CLS Cell Lines Service GmbH
human ovarian cancer cell line skov 3 ![]() Human Ovarian Cancer Cell Line Skov 3, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/SK-OV-3+Cells/pmc13691625-47-1-13 Average 94 stars, based on 1 article reviews
human ovarian cancer cell line skov 3 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
ATCC
human ovarian cancer cell lines skov3 ![]() Human Ovarian Cancer Cell Lines Skov3, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/SK-OV-3/pm42982980-59-9-26 Average 99 stars, based on 1 article reviews
human ovarian cancer cell lines skov3 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
human cancer cell lines skov 3 ![]() Human Cancer Cell Lines Skov 3, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/SK-OV-3/pm42977224-301-3-24 Average 99 stars, based on 1 article reviews
human cancer cell lines skov 3 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
human sk ov 3 skov3 ovarian adenocarcinoma cells ![]() Human Sk Ov 3 Skov3 Ovarian Adenocarcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/SK-OV-3/pmc13751463-61-0-10 Average 99 stars, based on 1 article reviews
human sk ov 3 skov3 ovarian adenocarcinoma cells - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
sk ov 3 ![]() Sk Ov 3, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/SK-OV-3/pmc13762552-551-0-5 Average 99 stars, based on 1 article reviews
sk ov 3 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
skov3 ![]() Skov3, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/SK-OV-3/pmc13673102-62-0-2 Average 99 stars, based on 1 article reviews
skov3 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
ovarian adenocarcinoma sk ov 3 ![]() Ovarian Adenocarcinoma Sk Ov 3, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/SK-OV-3/pm42883230-217-13-16 Average 99 stars, based on 1 article reviews
ovarian adenocarcinoma sk ov 3 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
human sk ov 3 ![]() Human Sk Ov 3, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sk+ov/SK-OV-3/pm42880285-1415-258-260 Average 99 stars, based on 1 article reviews
human sk ov 3 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
Journal: Bioinorganic Chemistry and Applications
Article Title: Identifying Drug‐Induced Metabolic Signatures in Comparative Untargeted NMR Metabolomics Using Difference Spectra
doi: 10.1155/bca/9636071
Figure Lengend Snippet: Principal component analysis (PCA) of the NMR profiles. (A) PCA score plots derived from Bspectra of treated cell lysates (left, proportion of variance: PC1 (0.528), PC2 (0.276)) and respective growth media (right, proportion of variance: PC1 (0.985), PC2 (0.0068)). (B) PCA score plots of average Bdifference_spectra of cell lysates (left, proportion of variance: PC1 (0.786), PC2 (0.088)) and growth media (right, proportion of variance: PC1 (0.991), PC2 (0.0048)). (C) PCA score plot of concatenated average Bdifference_spectra (cell lysates + growth media); proportion of variance: PC1 (0.866), PC2 (0.0923). Symbols indicate cell lines: A2780 (circles) and SKOV‐3 (diamonds). Colors indicate treatment: AF (blue); AuTM (red); CN1 (green); and CN2 (yellow).
Article Snippet: The
Techniques: Analysis, Derivative Assay, Nuclear Magnetic Resonance
Journal: Bioinorganic Chemistry and Applications
Article Title: Identifying Drug‐Induced Metabolic Signatures in Comparative Untargeted NMR Metabolomics Using Difference Spectra
doi: 10.1155/bca/9636071
Figure Lengend Snippet: Cluster cohesion analysis of PCA derived from NMR profiles. PCA score plots derived from (A) Bspectra of treated cell lysates; (B) Bspectra of treated growth media; (C) concatenated average Bdifference_spectra (cell lysates + growth media). In each score plot, the cluster centroids are shown as black‐contoured large dots; the respective average silhouette width ( s ) and p values from the permutation tests on centroid distances ( p ) are also reported.
Article Snippet: The
Techniques: Analysis, Derivative Assay
Journal: Bioinorganic Chemistry and Applications
Article Title: Identifying Drug‐Induced Metabolic Signatures in Comparative Untargeted NMR Metabolomics Using Difference Spectra
doi: 10.1155/bca/9636071
Figure Lengend Snippet: Comparative analysis of metabolic dysregulation induced by the four selected gold(I) compounds and AF‐analogs. (A) Bar plots representing the dysregulation indices (average ± sd) for AF, AuTM, CN1, and CN2 in A2780 (left) and SKOV‐3 (right) cells. (C) Bar plots of the dysregulation indices (average ± sd) for all compounds in A2780 cells. Colors indicate treatments: AF (blue); AuTM (red); CN1 (green); CN2 (yellow); and AF‐analogs (AFCl, AFI, (Ph 3 P)AuI) shown as shades of blue.
Article Snippet: The
Techniques: Analysis
Journal: Bioinorganic Chemistry and Applications
Article Title: Identifying Drug‐Induced Metabolic Signatures in Comparative Untargeted NMR Metabolomics Using Difference Spectra
doi: 10.1155/bca/9636071
Figure Lengend Snippet: Dot plots of the pathway analysis results for the different treatments in A2780 and SKOV‐3 cells. Each enriched pathway is represented as a dot with color intensity and size reflecting the weighted average of the absolute values of the log2(FC) for the detected metabolites within each pathway, using metabolite importance as a weight. For each treatment and cell line, the pathway with the highest FC value was set to 100, and all other pathways were scaled proportionally.
Article Snippet: The
Techniques: Analysis
Journal: Bioinorganic Chemistry and Applications
Article Title: Identifying Drug‐Induced Metabolic Signatures in Comparative Untargeted NMR Metabolomics Using Difference Spectra
doi: 10.1155/bca/9636071
Figure Lengend Snippet: Integrated pathway and metabolite analysis of AF‐induced metabolic changes. (A) Sankey diagram showing the five most dysregulated pathways shared between A2780 and SKOV‐3 cells upon AF treatment, together with the associated metabolites. (B) Box plots of relative metabolite concentrations in the intracellular compartment (cell lysates, L). Intracellular levels of glutathione, glutamate, and glycine are shown for control (blue) and AF‐treated (cyan) A2780 and SKOV‐3 cells.
Article Snippet: The
Techniques: Analysis, Control
Journal: Frontiers in Cell and Developmental Biology
Article Title: Cell-death-associated inflammatory remodeling of the SPP1/KRT5 axis in high-grade serous ovarian cancer: multi-omics, single-cell, and irradiation validation
doi: 10.3389/fcell.2026.1949173
Figure Lengend Snippet: RT-qPCR validation of cell-death-associated stress-response candidates after in vitro irradiation in SK-OV-3 cells. SK-OV-3 cells (ATCC HTB-77) were exposed to 0 Gy (control) or 6 Gy X-ray irradiation. Total RNA was collected 24 h after irradiation, and relative mRNA expression of (A) SPP1, (B) HIF1A, (C) VEGFA, and (D) KRT5 was determined by RT-qPCR. Expression was normalized to GAPDH and calculated using the 2^-ΔΔCt method. Bars show mean ± SD from three independent biological experiments; **P < 0.01 versus the 0-Gy control (two-sided Student’s t-test).
Article Snippet:
Techniques: Quantitative RT-PCR, Biomarker Discovery, In Vitro, Irradiation, Control, Expressing
Journal: Frontiers in Cell and Developmental Biology
Article Title: Cell-death-associated inflammatory remodeling of the SPP1/KRT5 axis in high-grade serous ovarian cancer: multi-omics, single-cell, and irradiation validation
doi: 10.3389/fcell.2026.1949173
Figure Lengend Snippet: (A) PCA of the six SKOV3 libraries (top 1,000 variable genes, z-scored log2 (x+1)); KRT5+ red, KRT5-blue; sample labels annotated. (B) Volcano of moderated t-test results (KRT5+ vs. KRT5-); red points pass BH FDR<0.05 and selected genes are labeled. (C) Mean z-scores of the KRT5 CPC program (red) and SPP1 niche program (blue) per library; derived from this contrast (nominal P < 0.01, |log2FC|>1). (D) Expression of preset axis genes (log2 (x+1)) in KRT5+ vs. KRT5-libraries; points are individual libraries (n = 3 per group). (E) Six highest-ranked KEGG 2021 terms per derived signature; bars show -log10 adjusted P (0/60 tested terms passed adjusted P < 0.05). (F) Moderated-t log2 fold changes for axis genes (KRT5+ vs. KRT5-); stars denote BH-adjusted P < 0.05/0.01/0.001.
Article Snippet:
Techniques: Labeling, Derivative Assay, Expressing
Journal: Frontiers in Cell and Developmental Biology
Article Title: Cell-death-associated inflammatory remodeling of the SPP1/KRT5 axis in high-grade serous ovarian cancer: multi-omics, single-cell, and irradiation validation
doi: 10.3389/fcell.2026.1949173
Figure Lengend Snippet: (A) Hexbin of per-gene effects: SKOV3 KRT5+ vs. KRT5- (x) and scRNA EOC post-NACT vs. naive (y); axes are independent native scales with zero reference lines. (B) Heatmap of per-layer log2 fold changes for candidate genes; asterisks mark FDR<0.05 within that layer; gray = not tested. (C) Complete-case candidate genes ranked by |scRNA EOC log2FC| (descriptive ranking; no composite significance is claimed). (D) Univariate Cox hazard ratios (per SD) with 95% CI for SPP1 and six programs; dashed line at HR = 1. (E) Within-cohort z-scored SPP1 expression versus inflammatory program: TCGA-OV hexbin with pooled scRNA samples overlaid as diamonds; Spearman r is annotated for both cohorts. (F) Quantitative cross-layer evidence summary. Points show signed -log10 nominal P (red/right = positive effect; blue/left = negative effect), capped at ± 6; circles denote Spearman correlations and squares paired effects. The shaded band is nominal P ≥ 0.05.
Article Snippet:
Techniques: Expressing
Journal: iScience
Article Title: Lipid-based mRNA chimeric antigen receptor T cells for enhanced in vitro antitumor activity
doi: 10.1016/j.isci.2026.117390
Figure Lengend Snippet: In vitro antitumor efficacy and effector function of mRNA CAR T cells (A) Enlarged schematic of the real-time cytotoxicity assessment (RTCA) workflow. (B) Cytolysis of MDA-MB-468 cells at 24 h across various E:T ratios. (C and D) Cytokine secretion (IL-2, TNF-α, IFN-γ, and CD4/CD8 subset distribution). (E–G) Flow cytometry analysis of exhaustion markers. (H) Schematic illustration of the mechanism for mRNA-CAR delivery into T cells via lipid nanoparticles. (I) Cytolysis of SKOV3 cells at 24 h across various E:T ratios. (J) Supernatant cytokine secretion (IL-2, TNF-α, and IFN-γ) following coculture with SKOV3 cells. (K–N) Flow cytometry analysis of CD4/CD8 T cell subset distribution and exhaustion markers (LAG-3, TIM-3 and PD-1) on T cells over time in SKOV3 cocultures. Data represent mean ± SD from three independent biological donors. Data are presented as mean ± SD, n = 3 (independent biological replicates). The statistical analysis was measured by paired two-tailed t tests. ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p ≤ 0.0001, and ns indicates no significance.
Article Snippet:
Techniques: In Vitro, Flow Cytometry, Analysis, Two Tailed Test
Journal: iScience
Article Title: Lipid-based mRNA chimeric antigen receptor T cells for enhanced in vitro antitumor activity
doi: 10.1016/j.isci.2026.117390
Figure Lengend Snippet:
Article Snippet:
Techniques: Recombinant, Saline, Modification, Virus, Filtration, Membrane, Cell Isolation, Software, FCAP Assay, Sequencing